PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Ontario, Canada.\', \'Department of Clinical Biochemistry, Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.\', \'Abbott Diagnostics, Lake Forest, IL, United States.\', \'Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Ontario, Canada; Department of Clinical Biochemistry, Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada. Electronic address: vathany.kulasingam@uhn.ca.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0009-9120(21)00004-710.1016/j.clinbiochem.2021.01.003
?:doi
?:hasPublicationType
?:journal
  • Clinical biochemistry
is ?:pmid of
?:pmid
?:pmid
  • 33476578
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.984
?:rankingScore_hIndex
  • 95
is ?:relation_isRelatedTo_publication of
?:title
  • Anti-SARS-CoV-2 IgM improves clinical sensitivity early in disease course.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33476578>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33476578>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all